Video file
Work That Matters
We focus on prevention
Catching Cancer Earlier with an At-Home Test
Researchers at CMU are developing ways to catch cancer earlier than ever before by building a screening test that's able to detect cancer from the comfort of a patient’s own home.
Stage 1 Cancers Able to Be Detected
More than types
Developing Powerful Screening Tools
Carnegie Mellon University and University of Pittsburgh researchers have shown that a simple, noninvasive light-based technology could help doctors better track how sickle cell disease affects the brain as patients age.
Measuring What's Happening
In billion small blood vessels
What if we reimagined stress management?
CMU health psychologist uncovers different stress management strategies.
This research explores how people adapt and thrive under stress, with a focus on the mind-body connection and pathways to resilience.
We power medical breakthroughs
Researchers Rethink Chronic Pain
Across neuroscience, biomedical engineering and artificial intelligence, researchers from CMU’s Neuroscience Institute are exploring how pain is measured, understood and treated to support safer, more effective care.
U.S. Adults Living with Chronic Pain
in 4
Groundbreaking 3D-printing Technology
CMU researchers have created the first-ever 3D-printed finger brace that easily shifts from rigid to flexible which is key to speeding up recovery from injuries and returning to daily life.
Easy Finger Movement
Using piece
What if infections could be treated without antibiotics?
CMU researchers have uncovered a vulnerability in bacteria that could pave the way for an entirely new class of infection treatment.
The discovery doesn’t kill the bacteria — a tactic that often leaves behind resistant survivors — but targets a key mechanism that controls bacterial behavior. Drew Bridges, an assistant professor in Carnegie Mellon University’s Mellon College of Science, said the research could be an important tool in fighting the growing threat of antibiotic resistance.
We save lives
RNA Research Impacts Treatment of Neuromuscular Disorders
CMU researchers have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of muscular dystrophy, and other RNA-repeat expansion disorders.
People Affected by DM1
1 in
Tools to Better Understand Life-altering Conditions
To help scientists learn how epilepsy works at multiple levels in the brain, CMU researchers have built a new software package that displays brain activity data for epilepsy in a revolutionary way.
Epilepsy Patients That Can't Be Treated with Medication
Over million
From improving health outcomes and enhancing education, to strengthening national security and advancing trustworthy AI, our work makes life better for people everywhere.